🇺🇸 Phenobarbital Sodium Injection in United States
4 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 4
Most-reported reactions
- Disease Recurrence — 1 report (25%)
- Drug Interaction — 1 report (25%)
- Epilepsy — 1 report (25%)
- Mesenteric Vein Thrombosis — 1 report (25%)
Other Neurology approved in United States
Frequently asked questions
Is Phenobarbital Sodium Injection approved in United States?
Phenobarbital Sodium Injection does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Phenobarbital Sodium Injection in United States?
PharPoint Research, Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.